Equities research analysts at Macquarie started coverage on shares of Colgate-Palmolive Company (NYSE:CL) in a research note issued on Thursday, The Fly reports. The brokerage set a “neutral” rating on the stock.

Other analysts have also recently issued reports about the stock. Bank of America Corporation raised their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research report on Friday, June 30th. Jefferies Group LLC increased their price objective on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research report on Thursday, July 6th. Finally, Vetr lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a research report on Wednesday, May 17th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $75.82.

Colgate-Palmolive (CL) traded up 0.73% on Thursday, hitting $72.18. 2,011,401 shares of the stock traded hands. The firm has a 50-day moving average price of $71.59 and a 200-day moving average price of $73.29. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a market capitalization of $63.57 billion, a PE ratio of 26.82 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. During the same period last year, the business earned $0.70 EPS. The company’s revenue was down .5% compared to the same quarter last year. Analysts forecast that Colgate-Palmolive will post $2.89 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive Company (CL) Now Covered by Analysts at Macquarie” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/09/14/colgate-palmolive-company-cl-now-covered-by-analysts-at-macquarie.html.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the completion of the transaction, the insider now directly owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total transaction of $999,040.00. Following the transaction, the senior vice president now directly owns 88,598 shares of the company’s stock, valued at $6,322,353.28. The disclosure for this sale can be found here. Insiders have sold a total of 217,969 shares of company stock valued at $15,693,933 over the last three months. 1.02% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Chickasaw Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 218.3% during the 1st quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after purchasing an additional 11,605 shares in the last quarter. Meritage Portfolio Management increased its holdings in shares of Colgate-Palmolive by 0.3% during the 1st quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after purchasing an additional 255 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of Colgate-Palmolive by 4.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares in the last quarter. Israel Discount Bank of New York purchased a new position in shares of Colgate-Palmolive during the 1st quarter valued at approximately $1,349,000. Finally, ProShare Advisors LLC increased its holdings in shares of Colgate-Palmolive by 9.9% during the 1st quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock valued at $64,382,000 after purchasing an additional 79,323 shares in the last quarter. 73.16% of the stock is owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Fly

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.